COVID-19 & Cholangiocarcinoma

We know you rely on us for medically accurate and up-to-date information. CCF is here to help you navigate through this difficult time! We have been reviewing hundreds of sources to bring you the most relevant information regarding COVID-19 and cancer. We are very cognizant that the dangers of this outbreak are not just physical. It is important to protect ourselves from anxiety and depression that can be caused by fear, uncertainty, and social isolation. Therefore, we will be sending select periodic videos, links to other websites, and up-to-date medical and scientific information to help address the specific physical, mental, and emotional needs of our community.

The One-Two Punch: Cancer And Coronavirus

By Rick Pollock | March 25, 2020

You have cancer. Your treatment is difficult, laborious, expensive, and stressful- even on even the best of days.

Enter, coronavirus. What now?

We’re here for you

By Stacie Lindsey | March 24, 2020

In this uncertain time, we want you to know, wherever you are that we are with you. Distance and physical separation cannot break the bonds we have made in this community.

What COVID-19 does to the human body

By Rick Pollock | March 23, 2020

Home / COVID-19 / Munich design house Kurzgesagt explains in an easy-to-understand video what happens to the human body once it has been infected with COVID-19.…

COVID-19 Resources

By Laura Hnat | March 19, 2020

It’s likely that your email inbox is flooded with updates about the COVID-19 pandemic. This can be overwhelming for anyone. It is particularly troublesome for cancer patients.

Dealing with Uncertainty

By Geret Giles | March 17, 2020

During this tumultuous time, Dr. Geret Giles offers some advice on how to deal with uncertainty.

Dr. Geret Giles is a licensed psychologist with a private practice in Pleasant Grove, Utah…

COVID-19 Guide for CCA Patients

By Allison Deragon | March 13, 2020

The Cholangiocarcinoma Foundation (CCF) has been closely monitoring the global Coronavirus (COVID-19) situation and its potential impact on cholangiocarcinoma patients.